Reported in the Feb. 3, 2013, issue of the journal Nature Medicine, the researchers explored what had first appeared to be an anomaly among certain genetically modified mice with an abundance of epidermal growth factor in their bone marrow. The mice were protected from radiation damage, and the researchers questioned how this occurred.
"Epidermal growth factor was not known to stimulate hematopoiesis, which is the formation of blood components derived from hematopoietic stem cells," said senior author John Chute, M.D., a professor of medicine and professor of pharmacology and cancer biology at Duke University. "However, our studies demonstrate that the epidermal growth promotes hematopoietic stem cell growth and regeneration after injury."
Hematopoietic stem cells, which constantly churn out new blood and immune cells, are highly sensitive to radiation damage. Protecting these cells or improving their regeneration after injury could benefit patients who are undergoing bone marrow transplantation, plus others who suffer radiation injury from accidental environmental exposures such as the Japanese nuclear disaster in 2011.
The Duke researchers launched their investigation using mice specially bred with deletions of two genes that regulate the death of endothelial cells, which line the inner surface of blood vessels and are thought to regulate the fate of hematopoietic stem cells. Blood vessels and the hematopoietic system in these mice were less damaged when exposed to high doses of radiation, improving their survival.
An analysis of secretions from bone marrow endothelial cells of the protected mice showed that epidermal growth factor (EGF) was significantly elevated - up to 18-fold higher than what was found in the serum of control mice. The researchers then tested whether EGF could directly spur the growth of stem cells in irradiated bone marrow cultured in the lab. It did, with significant recovery of stem cells capable of repopulating transplanted mice.
Next, the Duke team tried the approach in mice using three different solutions of cells in animals undergoing bone marrow transplants. One group received regular bone marrow cells; a second group got bone marrow cells from donors that had been irradiated and treated with EGF; a third group got bone marrow cells from irradiated donors treated with saline.
The regular bone marrow cells proliferated well and had the highest rate of engraftment in the recipient mice. But mice that were transplanted with the cells from irradiated/EGF-treated donors had 20-fold higher engraftment rate than the third group.
Additional studies showed that EGF improved survival from a lethal radiation exposure, with 93 percent of mice surviving the radiation dose if they subsequently received treatment with EGF, compared to 53 percent surviving after treatment with a saline solution.
Chute said it appears that EGF works by repressing a protein called PUMA that normally triggers stem cell death following radiation exposure.
"We are just beginning to understand the mechanisms through which EGF promotes stem cell regeneration after radiation injury," Chute said. "This study suggests that EGF might have potential to accelerate the recovery of the blood system in patients treated with chemotherapy or radiation."
In addition to Chute, study authors include Phuong L. Doan, Heather A. Himburg, Katherine Helms, J. Lauren Russell, Emma Fixsen, Mamle Quarmyne, Jeffrey R. Harris, Divino Deoliviera, Julie M. Sullivan, Nelson J. Chao and David G. Kirsch.
The study was funded by the National Heart, Lung and Blood Institute (HL-086998-01); the National Institute of Allergy and Infectious Diseases (AI-067798-06, AI-067798-01); the National Institutes of Health (T32 HL0070757-33); the Barton Haynes Award and Duke University.
Sarah Avery | EurekAlert!
Older patients recover more slowly from concussion
06.10.2015 | Radiological Society of North America
Fatty liver disease and scarring have strong genetic component
02.10.2015 | University of California - San Diego
Ein interdisziplinäres Forscherteam hat den ersten Prototyp eines Miniatur-Teilchenbeschleunigers gebaut, der mit Terahertz- anstelle von Hochfrequenz-Strahlung funktioniert. Ein einzelnes Beschleunigungsmodul ist dabei nur 1,5 Zentimeter lang und einen Millimeter dünn. Die Terahertz-Technik verspricht eine Miniaturisierung um mindestens den Faktor 100, wie die Wissenschaftler um DESY-Forscher Franz Kärtner vom Center for Free-Electron Laser Science (CFEL) betonen. Sie stellen ihren Prototyp im Fachblatt „Nature Communications“ vor. Das CFEL ist eine Kooperation von DESY, Universität Hamburg und Max-Planck-Gesellschaft.
Für kompakte Terahertz-Beschleuniger sehen die Autoren zahlreiche Anwendungen in Materialforschung, Medizin und Teilchenphysik sowie bei Röntgenlasern....
An interdisciplinary team of researchers has built the first prototype of a miniature particle accelerator that uses terahertz radiation instead of radio...
Neuer physikalischer Effekt: Forscher entdecken elektrische Widerstandsänderung durch magnetische Wirbelstrukturen
Derzeit werden kleinste magnetische Wirbel – sogenannte Skyrmionen – als vielversprechende Kandidaten für Bits in zukünftigen robusten und kompakten...
At present, tiny magnetic whirls – so called skyrmions – are discussed as promising candidates for bits in future robust and compact data storage devices. At...
Forscher des Labors für Attosekundenphysik des Max-Planck-Instituts für Quantenoptik und der Ludwig-Maximilians Universität haben in Zusammenarbeit mit dem Center for Nano-Optics der Georgia State University in Atlanta (USA) simuliert, was passiert, wenn eine Schicht aus Kohlenstoff-Atomen mit starkem Licht bestrahlt wird.
Trifft Licht auf Elektronen, bewegen diese sich rasend schnell, innerhalb weniger Milliardstel von milliardstel Sekunden (Attosekunden). Was mit Elektronen in...
06.10.2015 | Veranstaltungen
05.10.2015 | Veranstaltungen
05.10.2015 | Veranstaltungen
06.10.2015 | Unternehmensmeldung
06.10.2015 | Seminare Workshops
06.10.2015 | Unternehmensmeldung